Clinical Trial

CD34 NU-Signals and Alzheimer’s Disease Human Trials Presentation With Tzu Chi Hospital and Beauty-Stem Biomedical, Subsidiary of Power-Stem Biomedical Group

Unveiling the Potential Breakthrough - Activating Stem Cells to Delay and Reduce Dementia and Depression RiskLOS ANGELES, CA / ACCESSWIRE…

1 year ago

Digital Biomarker Market Size to Grow USD 22360 Million by 2029 at a CAGR of 82.5% | Valuates Reports

BANGALORE, India, Sept. 14, 2023 /PRNewswire/ -- Digital Biomarker Market is Segmented by Type (Passive Digital Biomarker, Active Digital Biomarker),…

1 year ago

ProofPilot and Legacy Health Strategies Partner to Scale Patient Engagement Strategies Beyond the Trial

NEW YORK, Sept. 14, 2023 /PRNewswire/ -- ProofPilot, a leading provider of innovative clinical trial automation, and Legacy Health Strategies,…

1 year ago

Beacon Biosignals Receives FDA Clearance for AI-Assisted Sleep Monitoring Device Dreem 3S

Dreem 3S makes it easy to include sleep quality endpoints in biopharma clinical studies, helping to unlock new insights into…

1 year ago

EmVenio Research Partners with RealTime Software Solutions for Advanced Mobile-Optimized Technology Solutions

DURHAM, N.C., Sept. 14, 2023 /PRNewswire/ -- EmVenio Research, a global network of mobile research sites providing localized trial access to…

1 year ago

Cryoport Receives 2023 IMAPAC Asia Pacific Cell & Gene Therapy Excellence Award

Company Named "Best Cell & Gene Therapy Supplier – Cryogenic Storage" NASHVILLE, Tenn., Sept. 14, 2023 /PRNewswire/ -- Cryoport, Inc.…

1 year ago

HealthVerity appoints John Eckhart as Chief Technology Officer

Award-winning SaaS product developer to lead HealthVerity in continuing to move the healthcare market forward PHILADELPHIA, Sept. 14, 2023 /PRNewswire/…

1 year ago

FluidAI Medical Teams Up with Medtronic for Remote Monitoring via DIGITAL’s Continuous Connected Patient Care Project

KITCHENER, ON, Sept. 14, 2023 /PRNewswire/ - FluidAI Medical, a leading artificial intelligence (AI) startup and developer of the Stream™ Platform…

1 year ago

EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna’s Updated Covid-19 Vaccine in The European Union

The positive opinion follows the recommendation from regulators and global public health bodies to develop monovalent XBB.1.5 COVID-19 vaccines for…

1 year ago

Applied DNA Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals

Agreement Focuses on the Accelerated Development of LNP-encapsulated LineaDNA™ Vaccines to Eliminate the Use of Plasmid DNA and Reduce the…

1 year ago